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Summary 
P21 CfPImrlF1 is a CDK inhibitor regulated by the tumor 
suppressor ~53 and Is hypothesized to mediate Gl ar- 
rest. p53 has been suggested to derive antl-oncogenic 
properties from thls relationship. To test these no- 
tions, we created mice lacking ~21~‘~~“~‘. They de- 
velop normally and (unlike p53-‘- mice) have not devel- 
oped spontaneous malignancies during 7 months of 
observation. Non-, p21+ embryonic flbroblasts 
are signlflcantly deficient in their ablllty to arrest in 
01 In response to DNA damage and nucleotlde pool 
perturbation. p21-‘- cells also exhibit a significant 
growth alteration in vitro, achieving a saturation den- 
sity as hlgh as that observed in p53-‘- cells. In contrast, 
other aspects of ~53 function, such as thymocytic 
apoptosis and the mitotlc spindle checkpoint, appear 
normal. These results establish the role of ~21~‘~“““~’ 
in the 01 checkpoint, but suggest that the antl- 
apoptotic and the anti-oncogenic effects of p53 are 
more complex. 
The ability to control precisely the order and timing of cell 
cycle event8 is important for the maintenance of genomic 
stability and the prevention of mutations that can disrupt 
normal growth control (reviewed by Hartwell, 1992; Hart- 
well and Kastan, 1994). The timing of cell cycle progres- 
sion is regulated through controls called checkpoints. 
Checkpoints also monitor the physical integrity of DNA 
and coordinate cell cycle transitions. For example, in re- 
sponse to DNA damage, cell8 coordinately arrest cell cycle 
progression and induce the expression of gene products 
that facilitate DNA repair. Arrest in Gl is thought to prevent 
replication of damaged genetic templates, and arrest prior 
to M allows cells to avoid segregation of defective chromo- 
somes. 
Primary among mammalian checkpoint genes is the tu- 
mor suppressor p53 (reviewed by Hinds and Weinberg, 
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1994; Cox and Lane, 1995). ~53 mutations are the most 
commonly observed genetic lesion found in human neo- 
plasia (Hollenstein et al., 1991). Mice deficient in p53 de- 
velop normally, but are susceptible to spontaneous tumors 
8UCh that >70% develop tumors by 6 months of age (Done- 
hower et al., 1992; Jacks et al., 1994; Williams et al., 1994; 
Harvey et al., 1994). ~53 is required for arrest in Gl in 
response to DNA damage such as ionizing radiation (IR) 
and to perturbation of nucleotide pools (Kastan et al., 
1991,1992; Kuerbitz et al., 1992; Livingstone et al., 1992; 
Yin et al., 1992). In addition, ~53 is required for optimal 
apoptosis induced by DNA damage (Clarke et al., 1993; 
Lotem and Sachs, 1993; Lowe et al., 1993) and other 
agents (Canman et al., 1995). Recently, ~53 has been 
implicated in a spindle checkpoint that controls the ploidy 
of cells (Cross et al., 1995). Consequently, cells lacking 
~53 display a striking degree of genomic instability, show- 
ing high rates of aneuploidy and gene amplification (Living- 
stone et al., 1992; Yin et al., 1992). 
~53 is a transcription factor (reviewed by Hinds and 
Weinberg, 1994; Cox and Lane, 1995). In response to gene 
toxic stress such as DNA damage, ~53 protein levels in- 
crease by a poorly understood mechanism (Maltzman and 
Czyzk, 1964) and this alteration in ~53 is thought to result 
in transcription of target genes that mediate its many func- 
tions. Among its transcriptional targets are Mdm-2, a nega- 
tive regulator of ~53 thought to be involved in adaptation 
(Barak et al., 1993; Wu et al., 1993); cyclin G, of unknown 
function (Okamoto and Beach, 1994); Bax, a protein that 
promote8 apoptosis (Miyashita and Reed, 1995); GADD45, 
a protein involved in DNA repair (Smith et al., 1994); and 
~21~‘~““‘~~’ (El-Deity et al., 1993), an inhibitor of Gl cyclin- 
cyclin-dependent kinase (CDK) complexes (Harper et al., 
1993; Xiong et al., 1993; Gu et al., 1993) proliferating cell 
nuclear antigen (Flares-Rozas et al., 1994; Waga et al., 
1994), and DNAsynthesis(Nodaet al., 1994). p21up’mAF1 is 
a member of a related family of CDK inhibitors that include 
~27~‘~’ (Polyak et al., 1994; Toyoshima and Hunter, 1994) 
and ~57~‘~ (Matsuoka et al., 1995; Lee et al., 1995; re- 
viewed by Elledge and Harper, 1994; Sherr and Roberts, 
1995). However, unlike p21ap’p’mAF1, there is no evidence 
that these are regulated by ~53. In the case of ~57~‘~, 
positive regulation by ~53 has been ruled out (Matsuoka 
et al., 1995). 
Of the known transcriptional targets of ~53, p21 “p’mAF1 
is the most likely to control cell cycle arrest. It is induced 
by DNA damage in a p53dependent manner and is found 
associated with inactive cyclin E-CDK2 complexes (Dulic 
et al., 1994; El-De@ et al., 1994). Cyclin E-CDK2 com- 
plexes have been shown to be essential for the Gl to S 
phase transition (Ohtsubo et al., 1995). ~21~‘~‘~~~ can 
arrest the cell cycle in Gl when overexpressed (Harper 
et al., 1995). In Some fibroblast cell lines, ~21~~~~~~ basal 
expression is dependent on ~53; however, in embryonic 
and adult mouse tissues, basal expression is largely inde- 
pendent of ~53 (Parker et al., 1995; Macleod et al., 1995). 
Expression induced by y-irradiation in vivo is, however, 
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~53 dependent (Macleod et al., 1995). p21crplmAF1 is ex- 
pressed during embryogenesis primarily in a subset of 
cells that are amitotic, thus potentially contributing to cell 
cycle exit during differentiation (Parker et al., 1995). 
P21 clplmAF1 induction has also been observed in cell lines 
undergoing differentiation or senescence in vitro (Jiang 
et al., 1994; Steinman et al., 1994; Parker et al., 1995; 
Halevyetal., 1995; Nodaet al., 1994). Therefore, in theory, 
organisms may utilize ~21~‘~‘~~~ in many ways: in prolifer- 
ating cells in Gl, it may contribute to cell cycle transition 
timing or Gi arrest; in S phase cells, it may block proliferat- 
ing cell nuclear antigen and slow down DNA synthesis 
to facilitate repair processes; and in development, it may 
contribute to cell cycle arrest in terminally differentiating 
cells. 
To explore the role of p21 “p’mAF1 in development and 
as a mediator of ~53 function, we have created mice lack- 
ing the p21up1mAF’ gene by targeted gene disruption. We 
have determined that ~21~‘~‘~~~’ is responsible for only a 
subset of known ~53 functions. The implications of these 
findings with respect to tumorigenesis are discussed. 
Results 
Targeted Disruption of the p21cfplmAFq Gene 
Creates a Null Mutation 
The targeting construct ~21~ (Figure 1A) was used to 
delete exon 2 of the ~21~~‘~~~~ gene. This exon encodes 
about 90% of coding sequence of the ~21 cIpl/wAF1 protein 
(El-De@ et al., 1993), and its replacement through homol- 
ogous recombination is predicted tocreate a null mutation. 
Of 70 G418 and FIAU double-resistant embryonic stem 
(ES) cell clones analyzed by Southern blot analysis for 
homologous recombination, one contained a correct tar- 
geting event (Figure 16). Germline transmission was ob- 
tained from the injection of this ES clone into C57BU6.f 
blastocysts. Southern blot analysis indicated that about 
50% of agouti offspring were heterozygous for the tar- 
geted mutation (p21+‘-). 
P21 “p’mAF1 is expressed in most organs and tissues in 
a p53-independent manner during murine embryonic and 
postnatal development (Parker et al., 1995; Macleod et al., 
1995). To study the possible role of p21cfp1mAFr in murine 
development, we intercrossed mice heterozygous for the 
targeted disruption to produce homozygous offspring. For 
the sake of brevity, we will refer to the genotype using the 
abbreviated form, p21+ or p21-. These crosses gave rise to 
litters of normal size, with living, apparently normal p21-‘- 
offspring present at a frequency consistent with Mendelian 
inheritance. p21-‘- mice were monitored for evidence of 
illness or tumor formation weekly for up to 7 months, and 
peripheral blood examinations, which showed no evi- 
dence of red or white blood cell abnormalities, werecarried 
out at 4 months of age. Histological sections from Several 
organs, such as muscle, testis, vertebral bones, and brain, 
were examined and were found to be normal (data not 
shown). 
Cultured mouse embryonic fibroblasts (MEFs) were de- 
rived from day 14 embryos of the three possible geno- 
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Figure 1. Targeted Disruption of the p21 Gene Produces a Null Mu- 
tation 
(A) This targeting construct contains a 6 kb p21up’m*FI genomic se- 
quence with a PGK-neo cassette (Tybulewicz et al., 1991). inserted 
through Xbal (Xb) and Xhol O(h) sites, that eliminates a 3 kb genomic 
fragment containing exon 2 of the p21c*.p’“yH’ gene. Transcriptional 
directions of the neomycin (neo) and the thymine kinase (tk) genes 
are indicated by arrows. Prior to electroporation, the targeting vector 
was linearized at the indicated unique Not1 (No) site. Homologous 
recombination within the ~21 locus would introduce the neo gene and 
delete the endogenous exon 2 (2). Other abbreviations: Bg, Bglll; EC, 
EmRI; a, probe a; b, probe b. 
(B) Southern blot analysisof DNA isolated from parental ES cells(lanes 
1 and 3) and a targeted ES cell clone (lanes 2 and 4). As expected, 
the Bglll restriction fragment size change from 8 kb to 9 kb is seen 
in the targeted cells (lanes 1 and 2) using the fragment %P-labeled, 
0.7 kb Accl 5’ probe indicated in the insert map (see probe a in [A]). 
Correct targeting events were confirmed by analysis of the fragments 
produced following EmRl digestion and detected using the same 
probe (lanes 3 and 4). 
(C) Northern blot analysis of RNAs isolated from wild-type (Wt), p53+‘-, 
p53+, p21+‘-, and p21+ MEFs. About 2 ug of poly(A) RNA was loaded 
on the each lane. Following the transfer, the filter was first hybridized 
with the p21~~m*FI probe (see probe b in [A]) to detect expression. 
After stripping, the filter was hybridized with a ~53 cDNA probe (see 
Experimental Procedures) to detect ~53 expression. 
(D) Analysis of p21 protein in MEFs derived from mntrol and mutant 
mice. Whole-cell lysates of MEFs (at passage 5) derived from the indi- 
cated mouse genotypes were subjected to SDS-PAGE and immu- 
noblotting as described in Experimental Procedures. The portion of 
the blot containing proteins of <30 kDa was probed with a monoclonal 
antibody directed against mouse ~21, while the portion of the blot 
containing proteins of >30 kDa was probed with antiCDK2 as a loading 
control. C&2 mRNA in mouse cells is translated as two protein iso- 
forms of 32 and 40 kDa (Noguchi et al., 1993). 
types, wild-type, p21+‘-, and p21-‘-. These were compared 
with similarly derived p53+‘- and ~53” MEFs with respect 
to p21 “p1NyllF7 mRNA (Figure 1C) and protein (Figure 1 D). 
Very little p21c’p1mAF1 mRNA (about 2% of wild-type) could 
be detected in samples from p53deficient cells (Figure 
lC, lane 1). No p21c’p1mAF1 mRNA was detected in samples 
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Figure 2. Saturation Densities and Growth Properties of MEFs 
(A) Saturation density and growth analyses of MEFs at passage 3. 
Cells (105) from wild-type (+/+), p21 -I-, and ~53~~ (as indicated in the 
figure) were plated in replicate 35 mm culture dishes as described in 
Experimental Procedures. Cell number at each timepoint represents 
the average of duplicate plates. 
(6) Growth curves of MEFs at passage 5 to 6. The genotypes of each 
cell are indicated in the figure. 
from p21-‘- cells (Figure lC, lane 5), nor could p21c’p’mAF1 
protein be detected in samples from either p53- or p21- 
deficient cells (Figure 1D). Given these results and the 
extensive nature of the deletion, we conclude that this 
P21 cfplNy*F1 mutation is a null. 
Growth Properties of p21-‘- Cultured MEFs 
We examined the initial growth properties of these mutant 
ceils during culture in vitro. Accordingly, proliferation and 
saturation densities of wild-type, p21-I-, and ~53~‘~ MEFs 
were analyzed at two passage points. At lower passages 
(passages l-3), all of the cells, irrespective of their geno- 
types, grew quite rapidly and had similar growth rates be- 
fore becoming confluent (Figure 2A). All MEFs showed 
contact inhibition, but the monolayers formed by p21-‘- 
and p53-I- MEFs were more crowded than those formed 
by wild-type cells. In addition, the saturation densities of 
p53-I- cells were significantly higher than those of wild- 
type cells, while those of p21-‘- cells were intermediate 
between those of wild-type and p53-‘- cells (Figure 2A). 
At later passages (passages 5-15), as growth of wild- 
type Cells slowed, differences in the saturation densities 
between the p53-I- and wild-type MEFs became much 
more pronounced. p21-‘- MEFs behaved more like p53-‘- 
MEFs (Figure 28). Between passages 5 and 15, prolifera- 
tion of wild-type MEFs was significantly reduced, as seen 
by the passage 5 and 6 cells shown in Figure 28. Wild-type 
cells gradually accelerated growth rates between pas- 
sages 15 and 20, while the behavior of p21 -I- and p53-I- 
MEFs did not change (data not shown). 
The Role of p21 in p534ediated Gl Arrest 
In response to DNA damage, mammalian cells arrest the 
cell cycle. Although the number of points at which the 
cycle can arrest have not been fully elucidated, it is clear 
that there is a block to entry into S phase that is mediated 
in part by arrest in Gl . This cell cycle arrest is dependent 
upon the ~53 gene product. Although it is not clear how 
~53 achieves cell cycle arrest, it has been suggested that 
it is through the transcriptional activation of the p21 cfplNyAF1 
gene (El-De@ et al., 1993; Harper et al., 1993). To exam- 
ine the contribution of p21cfp’mAF1 to the Gl checkpoint, 
we examined the ability of wild-type and mutant MEFs 
to reduce the population of S phase cells in response to 
y-irradiation. 
Serum-stanred cells were irradiated and stimulated to 
enter the cycle by the addition of serum. Bromodeoxuri- 
dine (BrdU) was added with serum to allow detection of 
cells entering S phase. Cells were harvested 24 hr later, 
and the number having entered S phase were determined 
by bivariate fluorescence-activated cell-sorting (FACS) 
analysis. Incorporation of BrdU indicates cells in S phase 
(see the example shown in Figure 3A). As indicated in 
Figure 38, wild-type cells showed a 50% reduction in the 
number of S phase cells relative to unirradiated samples 
averaged over several experiments. By contrast, p53- 
defective cells showed nearly complete deficiency in the 
ability to arrest in Gl, with, on average, only 2.6% reduc- 
tion in response to y-irradiation, as previously reported 
(Kastan et al., 1992). p21 -I- cells had a phenotype interme- 
diate between wild-type and p53-‘- cells, showing, on aver- 
age, a 20% reduction in cells entering S phase. These 
results indicate that p21c’p’mAF1 partially mediates the role 
of p53 in Gl arrest in response to y-irradiation. In contrast 
with some cells (Kastan et al., 1992), significantly higher 
levels of irradiation was required to achieve a significant 
reduction in S phase cells with our wild-type MEFs. Control 
experiments with WI36 cells, a normal human fibroblast 
strain, demonstrated that 5 Gy was sufficient to reduce S 
phase cells from 36% to 3% (data not shown), controlling 
for the proper calibration of our radiation source and con- 
firming the increased radioresistance of our MEFs. 
In addition to y-irradiation, cells can arrest in 61 in re- 
sponse to other types of damage or metabolic perturba- 
tions. N-(phosphonacetyl)-L-aspartate (PALA) is a specific 
inhibitor of de novo uridine biosynthesis (Swyryd et al., 
1974) that works through inhibition of the CADgene (Wahl 
et al., 1979). Cells treated with PALA show a p53- 
dependent decrease of entry into S phase (Yin et al., 1992; 
S. Linke and G. Wahl, personal communication). We ex- 
amined the role of ~21~‘~‘~~ in cell cycle arrest in re- 
sponse to PALA. Asynchronous cells were treated with 
varying amounts of PALA for 46 hr and then labeled for 
30 min with BrdU to identify cells in S phase. Both p53-I- 
and p21-‘- cells display a decrease in the Gl population 
relative to wild-type cells and an increase in S phase cells 
(Figure 4A). 
The large increase in the S phase population is thought 
to arise from cells that fail to arrest in Gl, enter S, and 
become arrested there owing to a lack of dTTP caused by 
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Figure 3. MEF Lacking ~21~~‘~~’ Display a Defect in the Ability to 
Block S Phase Entry after T-Irradiation 
(A) A representative bivariate flow cytometric analysis of synchronized 
wild-type @VT), p21-I-, or ~53’ MEFs 24 hr after exposure to 0 or 20 
Gy T-irradiation. Serum-starved cells(4days in mediacontaining 0.1% 
FBS) were released into complete media containing BrdU (65 PM) and 
immediately irradiated. At 24 hr after release, cells were harvested 
and stained for DNA content with propidium iodide and for replicative 
DNA synthesis with a fluorescein isothiocyanate-conjugated anti- 
BrdU antibody. Boxes labeled 1, 2, and 3 indicate Gl, S, and G2/M 
phase cells, respectively, and the percentages of cells in each phase 
of the cycle are indicated for each diagram. Approximately 3000 cells 
were examined in each analysis. 
(B) Quantitative analysis of the effects of y-irradiation on the number 
of cells entering S phase for wild-type @VT), p21-‘-, and p!XT-” MEFs. 
The percentage of cells entering S phase (BrdU+) after irradiation rela- 
tive to unirradiated cells is shown along with standard deviations for 
replicate experiments; n refers to the number of independent determi- 
nations for each strain. 
PAlA. Interestingly, p21deficient cells show a significant 
increase in G2 cells that is not observed in p53defective 
fibroblasts. This may indicate a p214ndependent, p53- 
dependent function in G2 arrest in response to PALA treat- 
ment. Although more in-depth experiments are required 
to confirm this possibility, a role for ~53 in G2 arrest has 
been previously reported (Stewart et al., 1995; Aloni- 
Grinstein et al., 1995). At higher concentrations of PALA, 
it becomes difficult to measure precisely the S and 62 
contents in p21-‘- and p53-‘- cells, as aberrant patferns 
of BrdU incorporation are observed in FACS analysis. Nev- 
ertheless, it is clear that the p21 -I- fibroblasts are defective 
in the Gl checkpoint activated by nucleotide depletion, 
thereby implicating p21ap’p’mAf1 as a significant mediator 
of the checkpoint function of ~53 in response to nucleotide 
depletion. 
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Figure 4. Absence of a Functional PALA-Induced Gt Checkpoint in 
p21-‘- MEFs 
(A) Effects of PALA on the cell cycle distribution of asynchronous 
MEFs. Asynchronous MEFs (passage 3) of the indicated genotypes 
were treated with various concentrations of PAtA for 48 hr. Cells were 
pulse labeled with BrdU (SO min), harvested, and analyzed for DNA 
synthesis and DNA content by FACS analysis as described for Figure 
3. Below is the quantitation of cell cycle phase distribution for these 
cells after PALA treatment. 
(B) Effects of PALA on S phase entry of synchronized MEFs. The 
indicated MEF cultures at passages 3 and 4 were serum starved for 
84 hr prior to addition of the indicated concentrations of PAtA for 12 
hr, and then the cells were released into growth media containing the 
same concentrations of PAfA and BrdU (65 CM). At 24 hr, cells were 
harvested and subjected to bivariate flow cytometric analysis. The 
percentage of cells entering S phase (BrdU+) in the presence of PAfA 
normalized to the number of cells entering S phase in the absence 
of PALA is shown. The percentage of cells entering S phase in the 
absence of PAfA was 41%. 32%, SO%, and 62% for wild-type (WT), 
p21 +I-, p21-‘-, and p!W-, respectively. 
Interpretation and quantitation of the pulse-labeling re- 
sults on asynchronous cultures are complicated in part by 
the fact that cells can arrest in Gl, 62, or M and thereby 
prevent S phase entry. To measure more precisely the 
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effects of PALA on the Gl to S phase transition, we per- 
formed experiments using synchronized cells. Serum- 
starved cells were stimulated to enter the cycle in the pres- 
ence of PALA and BrdU by the addition of serum. Cells 
were harvested 24 hr later, and the number having entered 
S phase were quantitated by bivariate FACS analysis (Fig- 
ure 48). As observed in asynchronous cells, both p21-‘- 
and p53-‘-cells show a nearly complete defect in Gl arrest 
relative to wild-type and p21+‘- cells. Unlike the results 
with y-irradiation, the defect in PALAdependent arrest in 
p21-I- cells appears to be nearly as severe as the defect 
with p53-‘- cells. This difference may be due to the precise 
position in the Gl to S phase transition that cells arrest 
in response to the different treatments, to the additional 
pathways activated by the stimuli, or to the degree of acti- 
vation of the p53 protein itself. 
p21CfMMAF’ Is Not Required for the Function of the 
p53-Dependent Mitotic Spindle Checkpoint 
In addition to the Gl checkpoint, p53 controls a mitotic 
spindle checkpoint (Cross et al., 1995). Wild-type fibro- 
blasts treated with the microtubule inhibitor colcemid ar- 
rest with a 4N DNA content. However, cells defective for 
p53 fail to arrest and proceed through the cell cycle, be- 
coming polyploid. Wild-type, p21-‘-, and p53’ fibroblasts 
were examined for their ability to arrest the cell cycle in 
response to colcemid (Figure 5). While p53-‘- cells fail to 
arrest in the presence of colcemid and accumulate sub- 
stantial quantities of polyploid cells, p21 -I- and wild-type 
cells have intact mitotic checkpoints. 
In the absence of spindle inhibitors, 50% of p53-‘- MEFs 
became tetraploid at passage 7 (Cross et al., 1995) and 
nearly all p53-‘- MEFs became tetraploid or polyploid at 
passage 9 (Livingstone et al., 1992). To determine whether 
P21 cIpl/wIF1 is involved in maintaining the chromosomal 
ploidy during culture, we determined chromosome num- 
bers for wild-type, p21-I-, and p53-‘- MEFs at passages 
3 and 15. The chromosome number was obtained by 
counting 50 intact metaphase spreads of each cell type. 
At passage 3, wild-type and p21-/- MEFs had a similar 
karyotype; i.e., 90% of cells had a typical diploid chromo- 
somal number of 40 and <lo% cells were tetrapoid. In 
contrast, 30% of ~53” cells became tetrapoid or poly- 
ploid, and an additional 10% contained chromosome num- 
bers between 62 and 76. At passage 15,30% of wild-type 
and 40% of p21 -I- MEFs had 40 chromosomes, whereas 
>90% of the p53-‘- MEFs were aneuploid, tetraploid, or 
polyploid. Thus, p21 cfp’mAF1 is not required for the opera- 
tion of the mitotic spindle checkpoint. 
~21~‘~“““~’ Is Not Required for 
p53-Dependent Apoptosis 
Thymocytes readily undergo apoptosis after DNA damage 
in a p53dependent manner (Lowe et al., 1993; Clarke et 
al., 1993). To determine whether ~21~‘~‘~~~~ is required 
for this process, we isolated thymocytes from wild-type, 
p21-‘-, and p53-‘- mice and determined the percentage 
of apoptotic cells after y-irradiation. As shown in Figure 
6A, wild-type and p21-‘- thymocytes show a dramatic in- 
crease of percentages of cells undergoing apoptosis (from 
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Figure 5. The p53Dependent Spindle Checkpoint induced by Col- 
cemid Is Functional in ~21” MEFs 
Asynchronous wild-type (WT), p21f, and p53-‘- MEFs at passage 3 
were incubated in the absence or presence of 566 q/ml colcemid for 
24 hr. Cells were harvested and the DNA content determined by flow 
cytometry after DNA staining with propidium iodide. DNA content ffow 
cytometric histograms are shown, as are the positions of peaks for 
2N, 4N, and 6N DNA content. At least 3MM cells were examined in 
each experiment. 
about 10% to SO%), whereas the p53-/- thymocytes show 
only a slight increase of apoptotic cells. Cell death by 
apoptosis was confirmed by gel electrophoretic analysis 
of genomic DNA (Figure 6B). The DNA fragmentation pat- 
terns displayed by wild-type and ~21” thymocytes were 
prominent and indistinguishable, while that of the p53+ 
thymocytes was greatly reduced by comparison. Thus, it 
appears that p53dependent apoptosis in mouse thymo- 
cytes does not require p21 “p’/wAF1. 
Absence of Accelerated Tumorigenesis 
in p21+ Mice 
p53deficient mice display a marked and rapid rate of early 
tumorigenisis (Donehower et al., 1992; Jacks et al., 1994). 
Since p21 “plMAF1 is regulated by p53 and is involved in 
the Gl DNA damage checkpoint, it is conceivable that 
p21-‘- mice would also display increased rates of tumori- 
genisis. To date, we have carefully followed 12 p21 -I- mice 
who are now >7 months of age (and >20 mice now be- 
tween the ages of 3 and 4 months). In contrast with p53-‘- 
mice, >70% of which develop tumors by 6 months of 
age (Donehower et al., 1992) none of the p21-‘- mice 
developed malignancies, indicating that p53-dependent 
suppression of early tumor formation does not require 
ClPVWAFl p21 . 
Obviously, these p21-‘- mice will be followed into old 
age, and a propensity for late tumorigenesis may emerge. 
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Figure 6. Induction of Apoptosis in p21-‘- Thymocytes 
(A) Percentages of thymocytes that undergo apoptosis after irradiation 
at 0 or 20 Gy. After irradiation, the wild-type (+I+), p21-‘-, and ~53~‘~ 
cells were cultured at 37W for 8 hr before analysis by FACS (Telford 
et al., 1994). 
(B) Gel electrophoresis of genomic DNA isolated from wild-type (+/+), 
p21-‘-, and p53- thymocytes with and without y-irradiation. Lanes 1, 
4, and 7 were DNA isolated at time 0 without IR treatment. Lanes 2, 
5, and 9 were DNA isolated at 9 hr without IR treatment. Lanes 3, 6, 
and 9 were DNA isolated at 9 hr after IR treatment. Lane 10 was XDNA 
digested by Hindlll. 
Moreover, in view of the effect that p21c’p1mAF1 has on the 
Gl DNA damage checkpoint, it will be important to assess 
the radiation sensitivity of these mice. Further, since we 
find an even greater sensitivity to tumorigenesis as we 
breed the p53- allele into an inbred FVB genetic back- 
ground (all of >30 p53-‘- mice followed developedtumors 
before the age of 6 months [C. D. and P. L., unpublished 
data]), it will be of interest to follow these mice as the p21- 
mutation is passed into various inbred backgrounds in an 
effort to discover modulating genes. Moreover, in view of 
the possibility that other members of the p21 class of CDK 
inhibitors might support functions in which ~21 normally 
participates, it is worth noting that preliminary experiments 
indicate that mRNAs corresponding to the related CDK 
inhibitors p27 and p57 are present in roughly equivalent 
amounts in MEFs derived from wild-type and p21-‘- mice 
(data not shown). 
DNA Damage-Induced GllS Arrest Is Partially 
Dependent upon p21 “PIlW~F7 
An extensive literature has emerged concerning the puta- 
tive roles of p21 CIP’/WAF1 in cell cycle control, cancer, and 
development. In particular, it has been suggested that 
P21 cIpl/wAFr may mediate some or all of the known functions 
of ~53. This work provides direct evidence that p21Qp’p’m*F1 
is necessary for efficient p53-dependent cell cycle arrest 
in response to DNA damage and metabolic perturbation 
and is, therefore, a bone fide effector of ~53. In response 
to PALA, Gl arrest in p21-‘- cells appears nearly as defec- 
tive as in p53-‘-cells. However, in response toy-irradiation, 
the Gl checkpoint is only partially impaired, indicating a 
second p53dependent function capable of arresting the 
cell cycle in Gl . The difference between inducing agents 
may reflect a difference in the extent of p53 activation that 
could alter which arrest mechanism is activated. Alterna- 
tively, the position in the cycle when the PAtA signal is 
sensed might preclude one of the arrest mechanisms. 
The nature of the second checkpoint mechanism is un- 
clear but could involve Gadd45, a p53dependenL DNA 
damage-inducible gene that can arrest the cell cycle when 
overexpressed (Smith et al., 1994). However, it is not clear 
that Gedd45 can arrest the cell cycle under physiological 
conditions. Alternatively, other mechanisms, such as de- 
phosphorylation of the activating threonine residue (T160 
in CDK2), activation of additional CDK inhibitors, or inhibi- 
tory phosphorylation, might be used to inactivate CDKs. 
A fraction of CDK2 is tyrosine phosphorylated on Y15 
(Elledge et al., 1992; Gu et al., 1992), and the conserved 
T14 is also a potential target for inhibitory phosphorylation. 
These phosphorylations are known to inhibit CDKs. Of 
course, cells could arrest through a CDK-independent 
mechanism. Regardless of the nature of the mechanism, 
the availability of p21-‘- cells will facilitate its elucidation. 
P21 upl/wAF1 is not absolutely required for contact inhibi- 
tion or arrest in GO upon serum starvation. However, it 
does appear to mediate the effects of p53 on serum depen- 
dency, growth kinetics, and arrest density of fibroblasts 
grown in vitro. Unlike these functions and the Gl check- 
point, both the apoptotic response and the mitotic spindle 
checkpoint function normally in p21-‘- cells. An under- 
standing consistent with our results is summarized in the 
diagram shown in Figure 7 in which ~21~~‘~~~ accounts 
for only a subset of known p53 functions. 
Role of p21 in Terminal Differentiation 
P21 “P7/WAF’ expression during mouse development corre- 
lates with terminally differentiating tissue such as muscle, 
outer layers of the epidermis, and olfactory neurons (Par- 
ker et al., 1995). It has also been observed to be induced 
during differentiation of a number of cell types in vitro (Ji- 
ang et al., 1994; Steinman et al., 1994; Parker et al., 1995; 
Halevy et al., 1995). These observations have led to the 
hypothesis that p21 “p7mM’ might contribute to cell cycle 
exit and differentiation. The fact that the p21-‘- mice ap- 
pear to have normal development, both at the gross ana- 
tomical and histologic levels, indicates that any essential 
role for p21 crpl/wAF’ in terminal differentiation must be re- 
dundant. Kinetic analysis of ~21~‘~~~ induction in differ- 
entiating myoblasts in vitro has revealed that ~21~~“‘“~~’ 
is induced at a late stage of differentiation, long after DNA 
synthesis is blocked (J. W. H., unpublished data), indicat- 
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Figure 7. A Current View of the Integrated Actions of p21 and p53 
DNA damage leads to stabilization and activation of ~53, possibly via 
the ataxia telangiectasia gene product (Savitsky et al., 1995). The 
activated p53 protein (~53’) induces transcription of ~21~~~~’ and 
other genes involved in cell cycle arrest and DNA repair. Under certain 
conditions that are not completely understood, p53 activation can lead 
to apoptosis. In response to y-irradiation, p53dependent cell cycle 
arrest in Gl functions by both p21”~m”F’dependent and p21crp’p’mM’- 
independent mechanisms that are only partially redundant, while p53- 
dependent apoptosis in response to y-irradiation does not require 
p21crp1m*F’. In mouse cells, p53 also regulates reentry into S phase 
when mitosis is blocked, as in the case of the anti-microtubule agents 
colcemid and nocodazole (Cross et al., 1995). This function is indepen- 
dent of p21crprmrFr. p53 may also regulate ploidy in the absence of 
spindle interference because untreated ~53~’ cells rapidly increase 
ploidy with increased passage. 
ing a maintenance rather than causative role. It is not sur- 
prising that there would be redundancy in a process of 
such critical importance to the organism. Indeed, these 
mice provide a useful background in which to launch a 
search for the other cell cycle control elements that, along 
with p21 “p’mAF7, mediate growth arrest and differentiation. 
Clarification of the Tumor Suppressive 
Effects of ~53 
One of the attractive aspects of the role of ~53 as a tumor 
suppressor and as an inducer of the Gl cyclin-CDK inhibi- 
tor p21 “p7mAF’ was that one could link the function of these 
proteins and provide a convenient rationale for the ability 
of ~53 to counter the action of oncogenes. For example, 
an oncogene might promote inappropriate entry into the 
cell cycle and passage into S phase. The inability of ~53 
mutants to arrest cells in Gl in response to oncogene 
action might lead directly to increased proliferation of cells, 
presumably an important aspect of tumorigenesis. In its 
simplest form, however, this rationale is incorrect be- 
cause, unlike p53-‘- animals, p21-‘- mice do not exhibit 
a propensity for early tumorigenesis. Indeed, this finding 
nicely explains the failure to find mutations in the 
P21 “p’mAF’ gene in human tumors (Shiohara et al., 1994). 
There are several plausible explanations for the ab- 
sence of tumors in p21-‘- mice. First, the role of p21 “pl/wAF1 
in the Gl checkpoint might be partially redundant, as sug- 
gested by its intermediate effect on the irradiation check- 
point. Thus, p21-‘- cells might show an intermediate in- 
crease in genomic instability relative to p53-deficient cells. 
Such reduced effects in p21-‘- cells relative to p53+ cells 
can easily be translated into altered mutation frequencies 
that, when multiplied over several events, could pro- 
foundly influence the overall frequency of tumorigenesis. 
Alternatively, it is possible that other p21-independent ~53 
functions, such as apoptosis, may play a more significant 
role in tumorigenisis than the Gl checkpoint. Several on- 
cogenes, such as Bc12 (Strasser et al., 1993) specifically 
inhibit apoptosis, lending strong support to the notion that 
the role of ~53 in control of apoptosis is important for its 
tumor-suppressing activity. Finally, it is possible that these 
other functions in combination with a checkpoint defi- 
ciency are responsible for the tumor-suppressing role of 
p53 in vivo. 
Experlmental Procedures 
Targeting Vector 
Recombinant phage containing genomic DNA of the p21 locus were 
isolated from a 129 mouse library (Stratagene) by using a 454 bp 
fragment containing the second exon of the mouse p21 cIpI/wIF’ gene as 
a probe. This fragment was amplified by PCR using a 5’oligonucleotide 
(5’-TCTTCTGTTTCAGCCACAGGC-3’) and a 3’ oligonucleotide (Y- 
TGTCAGGCTGGTCTGCCTCC-3’) (El-Deiry et al., 1993). To construct 
the ~21” targeting vector, we subcloned a 6 kb Bglll-Xbal fragment 
that is 3’to the second exon of the ~21~~~~’ gene into BamHl and 
Xbal sites of pPNT (Tybulewicz et al., 1991). The resulting construct 
was cleaved with Xhol and Notl, followed by insertion of a 2 kb Xhol- 
Notl fragment (the Not1 site is from polylinker of the phage vector) that 
is 5’to the second exon of the p21 cIprMM’ gene. The finished construct, 
p21n”, is shown in Figure IA. 
Homologous Recombination In ES Cells and Generatlon of 
GermlIne Chimeras 
TCI EScells, developed byC. D., T. Wynshaw-Boris, and P. L. (unpub- 
lished data), were transfected with Notldigested p21m and selected 
with 6418 and FIAU. The culture, electroporation, and selection of 
ES cells were carried out as described previously (Deng et al., 1994). 
ES cell colonies that were resistant to both G418 and FIAU were picked 
and analyzed by Southern blotting for homologous recombination 
events within the p21crp’“y”F’ locus. Genomic DNAs from these clones 
and the parental TCI cell line were digested with Bglll and EcoRI. 
respectively, followed by the Southern blot transfer analysis using a 
0.7 kb Accl fragment 5’ to the targeting vector (Figure IB). 
ES cells heterorygous for the targeted mutation were microinjected 
into C57BU6 blastocysts to obtain germline transmission. The injected 
blastocysts were implanted into the uteri of pseudopregnant Swiss 
Webster (Taconic) foster mothers and allowed to develop to term. Male 
chimeras (identified by the presence of agouti coat color) were mated 
with NIH Black Swiss females (Taconic). Germline transmission was 
confirmed by agouti coat color in the Fl animals, and all agouti off- 
spring were tested for the presence of the mutated p21wprmrJ’ allele 
by Southern blot analysis using the same conditions for the detection 
of the homologous recombination event in the ES cells. 
Northern Blot 
RNA was isolated using RNA TeT-60 based on the protocol suggested 
by the manufacturer (Tel-Test, Incorporated). Poly(A) RNA was pre- 
pared using a kit purchased from Pharmacia. About 2 ug of poly(A) 
RNA from each sample was electrophoresed on the 1% agarose gel 
and transferred to a GeneScreen filter (New England Nuclear). The 
filter was then hybridized with the gP-labaled probes specific for the 
p21 and p53 genes. The probe for p21~p’M”Fr is the 454 bp fragment 
described earlier, and the p53 probe is a 1.2 kb EcoRI-Xbal fragment 
containing full-length p53 cDNA (Johnson et al., 1991). 
Cell Cultures and Treatments 
Primary MEFs were obtained from embryos 14 days after conception 
that were either wild-type, p21+‘, p21 -I-, p53+‘-, or p53-‘-, using estab- 
lished procedures (Robertson, 1987). p53+‘- and p53-” MEFs were 
derived from embryos obtained by intercrossing mutant mice created 
Cdl 
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by Donehower et al. (1992). Genotypes for each cell line were verified 
by Northern and Southern blot analysis. WI36 normal diploid fibro- 
blasts were from the American Type Culture Collection (CCI 75) and 
were used at passage 20. Cells were cultured at 37OC (5% CO*) in 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal 
bovine serum (FBS) supplemented with penicillin and streptomycin 
(growth medium). For GO synchronization by serum starvation, asyn- 
chronous cultures at 70%&O% confluence were washed with phos- 
phate-buffered saline and placed in DMEM containing 0.1% FBS for 
96 hr. For y-irradiation (IR), GO-synchronized cells were trypsinized 
and suspended in growth medium before IR treatment. Cells were 
irradiated in suspension at room temperature with a ‘=Cs r-ray source 
at a rate of 4.1 Gy per minute (1 Gy = 100 rads) and then replated 
into growth medium in IO cm dishes at 40%-60% confluence. For 
experiments involving colcemid, asynchronous cells were treated with 
500 rig/ml for 24 hr prior to analysis. For PALA experiments, asynchro- 
nous cells were incubated in DMEM containing 10% dialyzed FBS 
and the indicated concentrations of PAtA for 48 hr prior to harvesting. 
For synchronous experiments, cells were serum starved for 84 hr, and 
then PALA was added at the indicated concentrations and incubated 
for 12 hr prior to release into serum containing PAtA and BrdU (as 
suggested by S. Linke and G. Wahl, personal communication). IR 
and PAlA experiments were performed using cells at passages 2-4. 
Colcemid experiments were performed using passage 3 cells. 
Cell Cycle Analysis 
Replicattve DNA synthesis and DNA content were analyzed using bi- 
variate flow cytometry according to established procedures (Di Leo- 
nardo et al., 1994). In brief, cells were pulse labeled with 10 pM BrdU 
(Sigma) for 30 min or were continuously labeled with 65 KM BrdU, 
harvested, and fixed in 70% ethanol. Fixed cells were kept at -20°C 
until analysis. Cells were treated with 0.1 N HCI containing 0.7% Triton 
X-100, followed by heating at 95OC for 10 min and rapid cooling to 
denature the DNA. Cells were then incubated with fluorescein isothio- 
cyanate-conjugated anti-BrdU antibodies (Becton-Dickinson) and 
counter stained with propidium iodide containing RNase (20 pg/ml). 
The stained cells were analyzed on EPICS Profile equipment. Cell 
debris and fixation artifacts were gated out, and Gl, S, and G2/M 
populations were quantitated using EPICS software. In each experi- 
ment, similar numbers of events were analyzed. 
Protein Analysis 
Total cell protein (30 pg) from the indicated cells was prepared as 
described previously (Harper et al., 1993) and was subjected to SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) on a 12.5% gel, 
transferred to nitrocellulose, and probed with either a monoclonal anti- 
body (65) directed against mouse ~21~~~’ (provided by Dr. D. Hill, 
Oncogene Science) or antiCDK2 antiserum (Santa Cruz Biochemi- 
cals). Proteins were visualized by ECL (Amersham) using exposure 
times of 2 min for p21ap’mHt and 1 min for CDK2. 
Ceil Prollhratlon and Saturatlon Density Assaya 
Cell proliferation and maximal cell density (saturation density) determi- 
nations of the MEFs at passage 3 were carried out as described else- 
where (Xu et al., 1995). In brief. IO5 cells of each line were plated in 
DMEM with 10% FBS in a series of 35 mm culture dishes. The cultures 
were maintained for up to IO days, with changing media each day. 
Cells were counted daily with a hemccytometer. The proliferation study 
was repeated using MEFs at passages 5 and 6, this time using a larger 
container (60 mm culture dishes) to allow cells more time for growth 
before confluence. 
lnductlon of ApoptosJs In Thymocyter 
Thymocytes were isolated from wild-type, ~21~‘~. and ~53” mice at 
age 4-6 weeks in growth medium (SW above) and adjusted to a degsity 
of 1 x IO per milliliter. of this mixture, 10 ml was aliquoted into each 
10 cm dish. For each mouse, five plates were prepared. Thymocytes 
from one plate were used to isolate DNA at time 0, two plates were 
unirradiated, and two plates were y-irradiated with 20 Gy. These were 
subsequently incubated at 37OC for 8 hr. Half of the thymocytes from 
each of these plates were used for FACS analysis under the conditions 
described by Telford et al. (1994) and the rest were used for DNA 
extraction. 
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